ArticleCell reports. Medicine2026

Fatty-acid-based antimiR-23b delivery in the DMSXL model: A potential therapeutic strategy for brain dysfunction in myotonic dystrophy type 1.

Diego Piqueras-Losilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.